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In morphological terms, ‘‘form’’ is used to describe
an object’s shape and size. In dogs, facial form is
stunningly diverse. Facial retrusion, the proximodis-
tal shortening of the snout and widening of the hard
palate is common to brachycephalic dogs and is a
welfare concern, as the incidence of respiratory
distress and ocular trauma observed in this class of
dogs is highly correlated with their skull form. Prog-
ress to identify the molecular underpinnings of facial
retrusion is limited to association of a missense
mutation in BMP3 among small brachycephalic
dogs. Here, we used morphometrics of skull isosur-
faces derived from 374 pedigree and mixed-breed
dogs to dissect the genetics of skull form. Through
deconvolution of facial forms, we identified quantita-
tive trait loci that are responsible for canine facial
shapes and sizes. Our novel insights include recogni-
tion that the FGF4 retrogene insertion, previously
associated with appendicular chondrodysplasia,
also reduces neurocranium size. Focusing on facial
shape, we resolved a quantitative trait locus on
canine chromosome 1 to a 188-kb critical interval
that encompasses SMOC2. An intronic, transpos-
able element within SMOC2 promotes the utilization
of cryptic splice sites, causing its incorporation into
transcripts, and drastically reduces SMOC2 gene
expression in brachycephalic dogs. SMOC2 disrup-
tion affects the facial skeleton in a dose-dependent
manner. The size effects of the associated SMOC2
haplotype are profound, accounting for 36% of facial
length variation in the dogs we tested. Our data bringCurrent Biology 27, 1573–1584,
This is an open access article undnew focus to SMOC2 by highlighting its clinical impli-
cations in both human and veterinary medicine.
INTRODUCTION
The mammalian skull is an architectural wonder that illustrates
the intertwined relationship of form and function. The skull facil-
itates ingestion and respiration, provides protection for the brain,
and houses the visual, auditory, and olfactory systems. The skull
also functions in communication, defense, and reproductive be-
haviors. The pressures of natural selection have ensured that the
skull, a composite of bones, is multifunctional and is physically
matched to the environmental challenges it experiences.
Human intervention through domestication and artificial selec-
tionhas largelydisplaced the influenceof natural selectionon form
and function across domestic species. Themost profound effects
of human intervention across all terrestrial species can be
observed among skulls of the domestic dog, Canis familiaris [1].
Centuries of selective breeding has resulted in a broad radiation
in skull form [2] whereas restraints on function have been relaxed.
Some subpopulations of dogs display morphologies that are
highly reminiscent of human craniofacial anomalies, such as
brachycephaly-type craniosynostosis and midface hypoplasia.
In both species, brachycephaly and midface hypoplasia are
risk factors for developing severe morbidities, including respira-
tory [3], gastrointestinal [3, 4], ear- and eye-related morbidities
[3, 5], and neurological abnormalities [6]. Due to their rarity and
complex clinical presentation, most human patients with brachy-
cephaly will never receive a genetic diagnosis [7]. Conversely,
dogs represent abundant examples of morphologically varied
skull shapes.
Previous investigations of canine head shape using genome-
wide association studies (GWASs) and selective sweepmapping
highlighted an association between canine chromosome (CFA) 1
and brachycephaly [8–10]. In a binary design of brachycephalicJune 5, 2017 ª 2017 The Authors. Published by Elsevier Ltd. 1573
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
versus non-brachycephalic pedigree dogs, Bannasch et al. [11]
established a 296-kb haplotype that encompassed the thrombo-
spondin 2 (THBS2) gene. This study did not identify causal
genetic variants, and the effects of this locus on gene expres-
sion were not assessed [11]. Elsewhere, measurements and
geometric morphometrics were used to quantify skull shape,
revealing quantitative trait loci (QTL) associated with brachy-
cephaly on CFA1, CFA5, CFA18, CFA30, and CFAX and a
missense variant in the bone morphogenetic protein 3 (BMP3)
gene on CFA32 [8, 9].
A limitation of the aforementioned studies is their discon-
nected use of phenotype and genotype data. Skulls from osteo-
logical collections were used to generate surrogate phenotypes
(e.g., ‘‘breed averages’’) for use in GWASs [8, 9]. Though this
approach has proven successful for detecting QTL, this study
design is poorly suited for identifying causal variation, which is
not necessarily fixed within breeds whose complex traits are of
interest. These breed average study designs cannot utilize
mixed-breed dogs that represent a significant portion of extant
canines and whose admixture can help separate the phenotypic
effects of complex traits. Finally, mapping complex traits, such
as canine brachycephaly, is confounded by the need to separate
the influences that size has on shape (i.e., allometry) [12].
Our goal was to identify the causal genetic variation respon-
sible for canine brachycephaly. Computed tomography (CT)
from 374 dogs that include 84 Kennel Club (UK) recognized
breeds and 83 mixed-breed dogs were analyzed using geomet-
ric morphometrics. Morphological descriptors, coupled with
individuals’ genotypes, were used to conduct genome-wide
association analyses of skull size and shape. Our analysis of
size-controlled skull shape identified a highly significant QTL
associated with canine brachycephaly on CFA1, as well as
numerous other suggestive associations. Focusing on the
CFA1 QTL, we defined a 187.7-kb critical interval common to
30 of 37 brachycephalic dogs. We resequenced 28 brachyce-
phalic dogs to approximately 30-fold depth and filtered polymor-
phisms within the critical interval against variants called in 319
other resequenced canid genomes. Among five variants that
were retained, we detected a long interspersed nuclear element
(LINE-1) within the SPARC-related modular calcium binding
(SMOC2) gene. Transcript analyses revealed alternative splice
isoforms that occur in the presence of the LINE-1, causing the
incorporation of a premature stop codon after the eighth exon
of SMOC2’s canonical 13-exon transcript. SMOC2mRNA levels
are downregulated in a dose-dependent manner with the LINE-1
element. Models of phenotypic effect indicate that the LINE-1
insertion explains up to 36% of facial retrusion observed in our
study. Endogenously expressed (mouse) Smoc2 is observed in
the pharyngeal arches during development, and the viscerocra-
nia of Smoc2-null mice are dysmorphic. Our data suggest that
SMOC2 dysfunction is responsible for canine brachycephaly.
Understanding the developmental role of SMOC2 could have
health implications in human and veterinary medicine.
RESULTS
Canine Phenotypes and GWASs
CTs of referral patients were reconstructed to produce three-
dimensional isosurfaces (Figure 1A). We placed 86 landmarks1574 Current Biology 27, 1573–1584, June 5, 2017across skull isosurfaces to capture subtle morphological varia-
tion within and across patients (Figures 1B–1G and S1). This
study included 291 dogs that represented 84 breeds recognized
by the Kennel Club (UK). Eighty-three mixed-breed dogs were
also included (n = 374; Table S1). Landmarks were analyzed ac-
cording to morphological substructure (neurocranium, visceroc-
ranium, and mandible; Figure S1). Because form (size and shape
considered together) differs so greatly between dogs of various
breeds, we performed a Procrustes fit on the landmark data to
delineate size, followed by a regression of shape on size to re-
move the effects of allometry (size-related shape). Principal-
component (PC) analysis of distance matrices produced from
the regression residuals indicated that the first component,
PC1, accounted for 72.2% and 68.8% of variation in the viscer-
ocranium and mandible data, respectively. In the positive direc-
tion of viscerocranium PC1, many of the constituent bones of the
rostrum narrow mediolaterally and lengthen rostrocaudally.
These are shape changes consistent with dolichocephalic dog
breeds, such as the smooth collie (Figures 1B and 1F). The oppo-
site phenomena are true for negative PC1: the rostrum broadens
and shortens. This reflects the morphological changes that are
consistent with brachycephalic head conformation, such as
that seen in pugs (Figures 1E and 1F) [8, 13]. Individual breeds
cluster together by morphological trait (e.g., viscerocranium
shape and neurocranium size; Figure 1G), demonstrating the ac-
curacy of this approach to capture phenotypes and order dogs
based on their morphology.
Breeds can also be differentiated from one another by their
genomic structure (Figure S2) [9, 14, 15]. Set to k = 2,
STRUCTURE revealed the SNP ascertainment bias resulting
from the boxer-based dog assembly; breeds closely related to
the boxer including the bulldog, Dogue de Bordeaux, and Staf-
fordshire terrier, emerge as a ‘‘molosser’’ subpopulation [15].
Approximately one-third of the mixed-breed dogs in our
dataset also share this substructure. At k = 84, we observed
that the vast majority of owner-reported breed assignments
were accurate, though we note evidence of admixture among
some of the pedigree dogs.
GWASs of the neurocranium size, as well as viscerocranium
and mandible shapes, showed little genetic inflation (Figures 2
and S3). The analysis of neurocranium centroid size identified
32 associated SNPs, representing five genomic loci (Figure 2A;
Tables1andS2). In adistinction frompreviousGWASs that inves-
tigated body size [16], our data suggest that these loci modulate
skull size. This result is particularly surprising for theCFA18 locus,
whoseunderlyingFGF4 retrogene insertion is correlatedwith limb
shortening in breeds like the Dachshund but was not known to
reduce skull size, as suggested by our data [17].
Three SNPs on CFA1 at 55862036, 55983871, and 56132332
were associatedwith viscerocraniumPC1 (Figure 2B). GWASs of
mandible PC1 also highlighted the CFA1 QTL (Figure S3).
Critical Interval Determination
The CFA1 QTL of viscerocranium andmandible PC1 correspond
to a broad selective sweep observed among brachycephalic
pedigree dogs [8–11]. Focusing on the CFA1 QTL, we observed
16 SNPs in linkage disequilibrium (LD) (r2 > 0.2) with the
index SNP (BICF2P250912; viscerocranium PC1; p = 1.91 3
1020; Figure 3A). First, we scanned for haplotype associations
Figure 1. Capturing Gross Interbreed and Subtle Intrabreed Variation in Skull Shape
(A) Three-dimensional isosurfaces of canine skulls are reconstructed from computed tomography (CT) scans of referral patients.
(B–E) Lateral images of a smooth collie (B; dolichocephalic), Bernese mountain dog (C; mesocephalic), border terrier (D; mesocephalic), and pug (E; brachy-
cephalic) with corresponding isosurfaces were included in our analysis. Head images and isosurfaces are not to scale.
(F) Lateral and dorsoventral views of the canine skull with wireframe diagrams superimposed, representing the changes in viscerocranium shape for negative and
positive viscerocraniumPC1 scores (‘‘ve PC’’). Red circles indicate surface landmarks of the rostrum. Connecting blue lines are added to provide visual context to
shape. Circles connected by black dotted lines indicate landmarks of the hard palate.
(G) Individual breed members cluster together when viscerocranium shape (viscerocranium PC1) is plotted against body size (neurocranium centroid). BMD-,
Bernese mountain dog; BORD, border collie; BORT, border terrier; BOX-, boxer; COLL, smooth collie; PUG-, pug; YORK, Yorkshire terrier.
See also Figures S1 and S2 and Table S1.extending 1 Mb away from the associated SNPs. This revealed
a single region of highly significant haplotypes between
55,881,672 and 56,020,217 (Figure 3B). Genotypes correspond-
ing to this interval, in addition to 500-kb flanking regions, were
phased and ordered in rank of each subject’s viscerocranium
PC1 value (Figure 3C). As the distribution of viscerocranium
PC1 score is bimodal (Figure 2B, inset), with brachycephalic
dogs corresponding to PC1 values less than 0.2, we reasoned
that the critical interval underlying the CFA1 QTL should be
established using haplotypes from this subset of dogs, as con-
stituents are more likely to be fixed for the underlying causal
variant(s) (Figure 3C). This revealed a 187.7-kb critical interval
(extending between CFA1 55,850,299 and 56,037,676) defined
by a 12-SNP haplotype. The 12-SNP haplotype is highly
enriched among brachycephalic dogs and was identified
among 63 of 74 (85.1%) chromosomes—it is found in just 28of 674 (4.2%) chromosomes of dogs with viscerocranium PC1
score > 0.2 (Table S3). Suggestive of an effect, the viscerocra-
nium PC1 value of these dogs was significantly different when
comparing haplotype carriers to non-carriers (Student’s t test;
p = 4.86 3 1049). Curiously, we identified two Dogues de
Bordeaux that did not carry the associated haplotype on
CFA1. However, our STRUCTURE analysis revealed a higher de-
gree of admixture in these two Dogues de Bordeaux compared
to others of the same breed (Figure S2), suggesting that they
were cryptic outbreds. Moreover, both dogs had longer viscer-
ocrania than those Dogues de Bordeaux that were fixed for the
12-SNP haplotype (data not shown).
Eight of the twelve SNPs of this haplotype are located
within the SPARC-related modular calcium-binding protein 2
(SMOC2) gene (Figure 3C). The remaining four SNPs are spread
across 43 kb of sequence downstream of the gene.Current Biology 27, 1573–1584, June 5, 2017 1575
Figure 2. Morphology of Skull Substruc-
tures Are Associated with Multiple QTL
Manhattan plots for neurocranium centroid size (A)
and viscerocranium PC1 GWASs (B). Red dashed
line (3.6 3 107) indicates threshold for multiple
testing with significant SNPs colored red. The
associated SNPs and candidate genes at each
locus are summarized in Table 1. Insets: skull
schematics indicate the region of landmarks used
for datasets. Expected (x axis) and observed
(y axis) log10(p) values are plotted for all SNPs
(black circles) and pruned SNPs (gray circles).
Histograms depict the frequency (y axis) of vis-
cerocranium PC1 and neurocranium centroid,
respectively. See also Figures S1 and S3 and
Table S2.Variant Filtering Analysis
Focusing on the CFA1 critical interval, we analyzed 187,377 bp
of whole-genome sequence. In total, we called 3,674 SNPs/
INDELS and 162 structural variants (Table 2). After hard filtering
(Table S4), four SNPs and one structural variant remained as
candidates for further consideration (Table 2; see STAR
Methods). All five remaining variants are located within introns
of the SMOC2 gene. The structural variant is a 1,531-bp inser-
tion, which is present in the dog reference genome (which was
generated from a brachycephalic breed—a boxer). The SNPs
and insertion appear in complete linkage disequilibrium (data
not shown). Though we cannot formally exclude their contribu-
tion to brachycephaly, none of the SNPs fell in regions of high
conservation across species (Figure S4). Thus, their potential
to cause brachycephaly was poorly supported.
Conversely, the insertion is a 30 truncated fragment of a class 1
long interspersed nuclear element (LINE-1). LINE-1 insertions
are known to be mutagenic in both man and dogs [18, 19]. The
LINE-1 insertion within SMOC2 is fragmented, possibly due to
incomplete insertion through ‘‘abortive’’ retrotransposition, and
includes an intact 30 UTR and 1,302 bp of ORF2 (Figure 4A)
[20]. We genotyped the LINE-1 fragment in subjects used in
our GWASs. The LINE-1 fragment is found among 91.5%
of chromosomes of brachycephalic dogs (viscerocranium
PC1 < 0.2) compared to only 2.1% of chromosomes of non-
brachycephalic dogs (Figure 4B). The LINE-1 fragment appears
to have no correlation with neurocranium centroid size (Fig-Table 1. SNPs Showing Genome-wide Significance with Skull Datas
Dataseta Chromosome Index SNP
Viscerocranium 1 BICF2P250912
Mandible 1 BICF2P250912
Neurocranium 3 TIGRP2P56799_rs8666557
Neurocranium 7 BICF2S23352941
Neurocranium 10 G580f46S240
Neurocranium 15 BICF2P355320
Neurocranium 18 BICF2S23615757
See also Table S2. For intragenic SNPs, genes are denoted by asterisks.
aOnly index SNPs are listed. A complete list of significant SNPs is shown in
bDerived alleles are shown after ancestral alleles
1576 Current Biology 27, 1573–1584, June 5, 2017ure 4C). Grouping individuals based on the number of LINE-1
fragment alleles they carried, we observe an additive effect for
all normalized linear measurements taken from skull isosurfaces,
with the greatest effect observed on the length of the palatine
bone (Figures 4D and 4E).
LINE-1 retrotransposons are known to alter local gene expres-
sion through a variety of mechanisms that affect transcription
[21–23]. Therefore, we quantified the relative expression levels
of SMOC2 mRNA at both the 30 and 50 ends of the transcript.
A comparable additive effect on SMOC2 expression was
observed across the transcript (Figure 4F). Subjects that were
homozygous for the SMOC2 LINE-1 allele had an5-fold reduc-
tion in total SMOC2 mRNA expression compared to individuals
without a copy of the allele. This observation was independently
confirmed by RNA sequencing. Subjects that were homozygous
carriers for the LINE-1 allele similarly had a significant reduction
in total SMOC2 mRNA levels when compared to non-carriers
(fold change = 3.1; Figure 4G). Three additional genes showed
significantly reduced expression, including two novel genes
for long non-coding RNAs (ENSCAFG00000039143 and
ENSCAFG00000035778) and the protein-coding urotensin 2B
(UTS2B) gene. None of these genes are located on CFA1. No
changes in expression of the neighboring genes to SMOC2,
THBS2, and DACT2 (dishevelled-binding antagonist of beta-
catenin 2) were observed (Figure 4G). Non-carriers of the
SMOC2 LINE-1 exclusively transcribed the ‘‘canonical’’ 13-
exon transcript of SMOC2 (Figure 4H). Homozygous carriersets
Position Candidate Gene Alleleb p Value
55,983,871 SMOC2* G > A 1.91 3 1020
55,983,871 SMOC2* G > A 8.43 3 1010
91,103,945 LCORL/NCAPG G > T 3.64 3 109
43,719,549 SMAD2* A > G 5.71 3 1013
8,183,593 HMGA2 C > T 3.06 3 1015
41,257,020 IGF1* C > T 1.73 3 1019
20,272,961 FGF4 retrogene A > C 3.31 3 108
Table S2.
Figure 3. Regional Association and Critical Interval Determination of the CFA1 Viscerocranium QTL
(A) SNP associations with viscerocranium PC1 are shown for1Mb on either side of significant SNPs on CFA1. SNPs are colored depending on the degree of LD
(r2) with the index SNP (BICF2P250912; 1.91 3 1020).
(B) Ten-SNP sliding window haplotype association.
(C) Genotypes between 55,881,672 and 56,020,217 (including 500 kb of flanking sequence) were phased and ranked by their viscerocranium PC1 value. Only
haplotypes from brachycephalic dogs (viscerocranium PC1% 0.2; see Figure S3) were considered. Haplotypes are paired by subject and ranked by viscer-
ocranium PC1 value. Alleles colored light gray match the consensus haplotype; dark gray alleles are variant. A 187.7-kb critical interval is defined by at least three
meiotic recombinations (indicated above by black bar). The 12 SNPs that constitute the associated haplotype (red bar) are distributed within or up to 44 kb
downstream of SMOC2. Black arrows indicate 3 of 37 dogs that have a homozygous variant haplotype. These dogs are registered as two Dogues de Bordeaux
and a Chihuahua. The red arrow indicates a Japanese Chin that is homozygosed for a recombinant haplotype within the critical interval.
See also Figures S2 and S6 and Table S3.for the SMOC2 LINE-1 similarly transcribed the canonical tran-
script; however, in addition to this, these individuals also tran-
scribed multiple different isoforms of SMOC2 (Figure 4H). Using
primers designed against exon 8 and the LINE, we identified
three isoforms present across all individuals homozygous for
the LINE-1 element and a further three rarer isoforms presentin homozygous or heterozygous carriers of the LINE-1 element
(Figure S5; Table S5). All isoforms incorporate the LINE-1
element and differing lengths of preceding intron into the
SMOC2mRNA following exon 8. Each of the different splice sites
within intron 8 are preceded by an adenine and guanine residue
(AG)—an almost invariant characteristic of mammalian spliceCurrent Biology 27, 1573–1584, June 5, 2017 1577
Table 2. Variant Filtering within the Viscerocranium Critical
Interval
Software GATK/SnpSft Pindel
Variant type SNPs/INDELS Structural variants
Base pairs analyzed 187,377 187,377
Pre-filtering 3,674 162
Post-filtering 4 1
Filtering criteria are listed in Table S4. See also Figure S4 and Table S4.acceptors (Table S5) [24, 25]. All alternative isoforms are pre-
dicted to introduce a premature stop codon following exon 8.
It is unclear whether the alternative truncated isoforms are trans-
lated; however, we predict the protein products would shear
within the thyroglobulin-like domain and would have no extracel-
lular calcium-binding domain (Figure 4I) [26].
In exon 8, we observed a SNP that encodes a silent C/T sub-
stitution at position 55,939,143. Interestingly, both the C and T
alleles are present across ‘‘ancestral’’ populations that do not
carry the LINE-1 element. However, the LINE-1 element is only
observed in the presence of exon 8’s T allele (Figure 4H). This
suggests that the C/T variant predates the insertion of the
LINE-1 variant. In heterozygous subjects, the C/T variant
enabled us to quantify the allele-specific transcriptional activity
of SMOC2. Transcripts from a Yorkshire terrier dog that was ho-
mozygous ancestral for the SMOC2 allele (lacking the LINE-1),
but heterozygous for the C/T allele, had an allele percentile ratio
of 46:54, suggesting that transcripts from both alleles are equally
represented (Table S6). In contrast, two Cavalier King Charles
spaniels that were heterozygous for both the SMOC2 LINE-1
and the C/T allele had allele percentile ratios of75:25, which in-
dicates that the DNA allele with the LINE-1 element contributes
fewer of the SMOC2 reads (Table S5). A lower abundance of
transcripts incorporating the LINE-1 element may suggest that
they are targeted by nonsense-mediated decay, decreased tran-
scriptional activity, or both.
Size-Effect Modeling on Skeletal Size and Shape
We were interested in modeling phenotypic effects of size and
shape using the skull-derived QTL described by our study and
elsewhere [8, 9, 16, 27]. The derived allele frequencies of associ-
ated markers of SMOC2, CFA30 QTL, BMP3, IGF1, and STC2
differ significantly according to viscerocranium PC1 (Figure 5A).
These five genotypes were applied as explanatory variables in a
linear stepwisemodel for the viscerocranium PC1. Alone, the ho-
mozygous-derived alleles of the SMOC2 LINE-1 explain the
largest amount of viscerocranium variation (R2 = 36%), with
markers at the CFA30 QTL, BMP3 IGF1, and STC2 explaining
28%, 12%, 4%, and 4%, respectively (Figure 5B). These vari-
ances are not additive but infer the maximum potential contribu-
tion of each genotype. Together, 45% of viscerocranium’s
proportion of variation explained (PVE) is explained by these
five genotypes. IGF1, IGF1R, SMAD2, FGF4, GHR(1), GHR(2),
CFA30 QTL, BMP3, STC2, HMGA2, and the LCORL/NCAPG lo-
cus are significantly associated with neurocranium centroid size
(Figure 5C). The best model for explaining variation in neurocra-
nium centroid size selected a subset of genotypes (SMAD2,
IGF1, FGF4, IGF1R, and the LCORL/NCAPG locus), which1578 Current Biology 27, 1573–1584, June 5, 2017together explain up to 68% PVE (Figure 5D). Individually, the ho-
mozygous-derived alleles of SMAD2, HMGA2, GHR(1), IGF1,
FGF4, STC2, IGF1R, the LCORL/NCAPG locus, GHR(2), the
CFA30 locus QTL, and BMP3 explain up to 47%, 37%, 31%,
29%, 28%, 22%, 21%, 14%, 10%, 8%, and 6%of neurocranium
centroid size variation, respectively (Figure 5D).
Species Conservation of SMOC2
Morpholino knockdown of zebrafish smoc2 suggests it regulates
head development [28, 29]. To determine whether SMOC2 func-
tion is evolutionary conserved across other species, we first
assessed its regional conservation by aligning the locus to the
human genome. Mouse and chick sequence conservation was
strikingly reduced compared to other species, including the
dog (Figure S6A). Despite this, embryonic expression in chick
and mice is observed in the first pharyngeal arch (Figure S6)
[30]. Notably, the cranial neural crest streams into the first arch
to populate the primordia that will give rise to the maxilla, as
well as other constituents of the viscerocranium and mandible
[31–33]. Previous to our study, Smoc2/ mice were generated
and phenotyped for the International Mouse Phenotyping Con-
sortium (IMPC). Although these mice are no longer maintained,
adults used for phenotyping were viable and fertile. We assessed
archived radiographs of Smoc2/ (n = 8) and strain-specific
controls (n = 4; Figure S7A). Principal-component analysis of
the whole head revealed similar morphological variation to that
which we observed in dogs. Murine PC1 variation showed
mediolateral widening and rostrocaudal shortening of the skull
(Figure S7B). PC1 values clustered differentially by genotype
(Smoc2 knockout versus control; p < 0.001; Figure S7C); how-
ever, no such segregation was observed for sex (Figure S7D).
Total palate length was assessed from lateral radiographs. The
palate was significantly shorter in transgenic mice (Student’s
t test; p = 0.0011), though not when allometry was removed (Fig-
ure S7E; data not shown). Given this observation and the fact
that the locus is poorly conserved might suggest species-level
differences in Smoc2 function. Nonetheless, our mouse data,
as well as additional bone phenotypes described by the IMPC,
indicate that disruption of Smoc2 is sufficient to adversely affect
craniofacial biology.
DISCUSSION
Studies, including ours, continue to demonstrate the effective-
ness of dog breeders at propagating aesthetic traits [8, 17, 34].
This cultivation of morphologies predated the formation of breed
clubs. The selective sweep and association of theCFA1QTLwith
brachycephaly was recognized in the early days of dog GWASs;
however, confirmation of the underlying causative genetics re-
mained elusive. Unlike QTL mapping, fine mapping approaches
based on haplotype comparisons are confounded by the occa-
sional ‘‘outlier’’ within a breed that is not fixed for or does not
even carry the genetic variant that drives a trait that is common
to other members of its breed. Moreover, whereas dog traits
(e.g., brachycephaly) that are common across subsets of breeds
are often driven by identity-by-descent genetics, this phenome-
non is not absolute. To avoid these issues, aswell as leverage the
genetics ofmixed-breed dogs,webuilt a study populationwhose
phenotypes and genotypes were derived individually.
Figure 4. Characterization of the Intronic LINE-1 Retrotransposon within SMOC2
(A) Schematic of a full-length canine LINE-1 element consisting of 50 UTR/30 UTR, open reading frames 1 and 2 (ORF1/ORF2), and a polyadenylated tail (AAAAn)
flanked by target site duplications (TSD). The structural variant within SMOC2 is 1,506 bp in length (in addition to a poly(A) tail) and has a 99.1% match to the
consensus sequence of canine LINE-1.
(B and C) Distribution of the SMOC2 LINE-1 fragment for (B) viscerocranium PC1 and neurocranium centroid size (C) across all individuals.
(D) Ventral-dorsal view of the canine hard palate and its constituent bones.
(E) Length andwidth of the canine palate and constituent bones normalized by the neurocranium centroid for homozygous ancestral (white), heterozygotes (gray),
and homozygous-derived (black) individuals for the SMOC2 LINE-1 insertion.
(F) Relative expression levels of SMOC2 both up- and downstream of the LINE insertion (<0.05 *; <0.01 **; <0.001 ***). Error bars represent SEM.
(G) RNA sequencing (RNA-seq) data reveal four genes with significant changes in mRNA levels (red) for homozygous SMOC2 LINE-1 carriers compared to non-
carriers (three each). Neighboring genes to SMOC2 are colored green.
(H) Schematic of genomic DNA (gDNA) spanning exon 8 and 9 of SMOC2, including the LINE-1 fragment. mRNA transcripts include the canonical splicing of
SMOC2 (i) followed by the three most abundant SMOC2 isoforms when the LINE-1 element is present (ii–iv). All isoforms have premature stop codons prior to
exon 9. C/T indicates the SNP in exon 8. Schematic is not to scale.
(I) Exons 1–13 of SMOC2 contribute to a follistatin-like module (FS), thyroglobulin-like modules (TY), a unique SMOC module, an extracellular calcium-binding
module (EC), and a signal peptide (SP).
See also Figures S5 and S7 and Tables S5 and S6.We distilled the CFA1 locus to reveal a haplotype overlapping
with SMOC2 as the major contributor to brachycephaly. We
strongly suspect that the insertion of a truncated transposable
element intoSMOC2 ismost likely causal; however, we acknowl-
edge the limitations of our study. The dog’s long-range linkage
disequilibrium prevented us from disassociating four SNPs that
are in linkage disequilibrium with the LINE. Whether or not these
variants have functional impacts cannot be dismissed. Second,whereas our transcriptional analysis demonstrates differential
expression and missplicing of SMOC2 that are associated with
the LINE insertion, we cannot say whether other genes are
affected by this haplotype in cis. Due to limited tissue availability,
we restricted our differential expression to testis, a tissue where
SMOC2 was assumed to be highly expressed based on evi-
dence from other species [35, 36]. In the future, additional tis-
sues will need to be tested to determine whether genes in cisCurrent Biology 27, 1573–1584, June 5, 2017 1579
Figure 5. Size Effects of the Viscerocranium Shape and Neurocranium Centroid Size QTL
(A and C) Boxplots depicting the distribution of normalized size-corrected viscerocranium PC1 (A) and normalized neurocranium centroid size (C) for 11 loci
linked with body size and skull shape. Distributions are subdivided by genotype —homozygous ancestral (AA), heterozygotes (AD), and homozygous derived
(DD). *** denotes p < 0.001 in Mann-Whitney-Wilcoxon and Kolmogorov-Smirnov tests.
(B and D) A stepwise linear regressionmodel for viscerocranium PC1 (B) and neurocranium centroid (D) determined the best explanatory model for ancestral (left)
and derived (right) genotypes for each positional candidate.are differentially expressed in association with the haplotype we
describe.
Modeling phenotypic variance was enhanced by the inclusion
of mixed-breed dogs, whose admixed genomes and lack of
standardization helped separate QTL that would otherwise co-
segregate. Alone, SMOC2 explains up to 38% of viscerocranium
PC1 variance. Whereas clearly the locus has a large effect size,
our study is currently underpowered to exhaustively detect QTL
that modulate brachycephaly or, more broadly, shape of the1580 Current Biology 27, 1573–1584, June 5, 2017facial skeleton. This is underscored by the fact that we have
not explained canine brachycephaly as it occurs in two Dogues
de Bordeaux and an Affenpinscher (the latter was used in our
whole-genome sequencing); none showed evidence of a selec-
tive sweep on CFA1 nor did they carry the associated 12-SNP
haplotype. Moreover, our GWASs failed to replicate the
CFA32/BMP3 and CFA30 QTL associations described previ-
ously [8]. A likely explanation for this is the modest numbers of
small, brachycephalic breeds in our study, as well differing
demographics. Our study is lacking in Brussel Griffon,
Pekingese, Boston terriers, and Japanese Chin—all brachyce-
phalic breeds whose members are typically homozygous for
the missense variant in BMP3.
By necessity, we cannot explain the genetics of skull shape
without addressing confounding effects of allometry, which is
essential in a species whose size differential can exceed 40-
fold. We used subjects’ neurocranium centroid size to remove
the influences of allometry from viscerocranium shape variation,
as well as to explore the genetics of neurocranium size itself.
A genomic association of neurocranium centroid size identified
five loci. Four of these loci were previously identified in body
size studies across a variety of species: SMAD family member 2
(SMAD2) [9, 16, 27], high-mobility group AT-hook 2 (HMGA2)
[9, 16, 27, 37–39], insulin-like growth factor 1 (IGF1) [16, 27],
and the ligand-dependent nuclear receptor corepressor-like
(LCORL)/non-SMC condensin I complex, subunit G (NCAPG)
locus [16, 40–42]. Our effect size data point to their relative
contribution to neurocranium centroid size; the largest effect
size is explained by the putative enhancer deletion at the
SMAD2 locus [27]. The association of neurocranium centroid
size with the fibroblast growth factor 4 (FGF4) retrogene was un-
expected. Parker et al. [17] first identified an FGF4 retrogene
associated with canine asymmetric chondrodysplasia, a form
of dwarfism that gives breeds like the Dachshund its short
legs. The same locus was associated with body weight [16],
though this could be explained by reduced leg mass. Our results
indicate that the bone-based structure of the neurocranium is
also reduced in size by the retrogene. Similarly, Hayward et al.
[16] identified an association to stature and body weight in
proximity to SMOC2 [16]. Because a high proportion of the
brachycephalic dog population are low-to-medium weight
breeds (Figure 1G), the interpretation of their association is un-
clear. In our study, we see no evidence that the SMOC2 locus
modulates neurocranium centroid size (Figures 2A and 5C)
and, by extension, skeletal size. However, we cannot exclude
the possibility that theQTL noted by the authors affect soft tissue
mass or appendicular bone length.
SMOC2 belongs to the BM-40 (SPARC) family of matricellular
proteins, which contain an extracellular calcium-binding module
and a follistatin-like domain. SMOC2 is distinguished from the
BM-40 family by the addition of two thyroglobulin domains and
a novel domain unique to the SMOC subgroup [26]. The
calcium-binding module facilitates the binding of multiple
collagen types [43] and the interaction with several growth fac-
tors [44, 45], which permits the proteins to function in cell adhe-
sion, cell proliferation, and matrix turnover (reviewed by [46]).
The BM-40 family was first identified in bone (where SMOC2
has been shown to be differentially expressed across the growth
plate) but has since been found in a wide variety of other tissues
[38, 47–49]. Mounting evidence suggests the SMOC2 plays an
important role in craniofacial form across species. Knockdown
of zebrafish smoc2 causes severe craniofacial hypoplasia [28],
a process that may act by downregulating target genes of
bone morphogenetic protein (BMP) signaling [50]. In chick em-
bryos, Smoc2 is prominently expressed in the pharyngeal
arches. Murine craniofacial development undergoes dynamic
growth between embryonic days 10.5 and 12.5. Throughout
this window, Smoc2 is shown to have differential temporalexpression in the frontonasal process and maxillary/mandibular
prominences [47]—tissues that give rise to mandible and viscer-
ocranial structures. Our geometric morphometric analysis of
radiographs indicate the skulls of Smoc2-null mice cluster
distinctly from wild-type, though a detailed understanding of
the shape changes that occur in null mice will require three-
dimensional analysis (Figure S7). It is intriguing that numerous
copy-number variants spanning SMOC2 are associated with hu-
man phenotypes, including brachycephaly, hydrocephalus, long
face (vertical), and hypertelorism [51]. Point mutations in SMOC2
were identified independently in patients with dentin dysplasia
type I syndrome, whose hallmarks include severe oligodontia
and microdontia [29, 52]. Finally, deleterious mutations in
SMOC2 were identified in DECODE [53] and Generation Scot-
land biobanks (M.L.B., unpublished data).
Leveraging the craniofacial diversity of dogs, we set out to
discover candidate genes involved in human craniofacial anom-
alies, particularly craniosynostosis and midface hypoplasia. Our
results suggest that SMOC2 should be screened as a candidate
for diagnosis. Not to be ignored, the role of SMOC2 dysfunction
and the associated haplotype we defined need further explora-
tion as they concern the health of brachycephalic dogs. As our
canine skull project continues to grow, we will explore the role
of SMOC2 and other skeletal QTL with comparative health
implications.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILSB DNA Extraction and Microarray Genotyping
B RNA Extraction and qPCR
B Sequencing Library Preparations
B Histology
d QUANTIFICATION AND STATISTICS
B Morphometrics
B Genotype Analyses
B Fine Mapping
B Variant Filtering
B qRT-PCR
B RNA-Seq
B Generation Scotland: Scottish Family Health Study
d DATA AND SOFTWARE AVAILABILITY
d ADDITIONAL RESOURCES
B DECIPHER
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and six tables and can be
found with this article online at http://dx.doi.org/10.1016/j.cub.2017.04.057.
AUTHOR CONTRIBUTIONS
Conceived and designed the experiments, T.W.M., E.J.J., R.J.M., D.N.C., and
J.J.S.; performed the experiments, T.W.M., E.J.J., L.M., and J.J.S.; performedCurrent Biology 27, 1573–1584, June 5, 2017 1581
the data analysis, T.W.M., E.J.J., M.L.B., L.M., M.G.D., and J.J.S.; diagnostic
image collection, C.I.J., A.G., T. Liuti, S.G., J.L., D.J.A., R.J.M., and T.S.; bio-
banking, T.W.M., E.J.J., C.I.J., A.G., M.N., D.K., M.D., R.M.P., D.J.A., G.T.H.,
T. Leeb, R.J.M., and J.J.S.; mouse data, K.S.; wrote the manuscript, T.W.M.,
G.T.H., and J.J.S. All authors revised the manuscript.
ACKNOWLEDGMENTS
The authors thank the many dog owners whose beloved pets enabled this
study. We would also like to acknowledge the many clinicians at the
R(D)SVSHospital for Small Animals, PTDS, DickWhite Referrals, Kleintierklinik
of Vetsuisse Faculty Bern, and Friendship Animal Hospital, who helped us
collect biospecimens used in our DNA and RNA analysis. Gonad tissue was
collected by J.J.S. with the support of E. Ostrander. Special recognition is
given to D. Gaylor, S. Campbell, J. Lawrence-Rausch, R. Elders, K. Jermyn,
A. de Castro Marques, S. Woods, Y. Martinez-Pereira, B. Corcoran, T. Nuttall,
D. Gow, K. Mellanby, and N. Bommer for their extraordinary efforts to enable
patient recruitment; the Dog Biomedical Variant Database Consortium
(G. Aguirre, C. Andre, D. Bannasch, D. Becker, C. Dro¨gemu¨ller, O. Forman,
S. Friedenberg, E. Furrow, U. Giger, C. Hitte, M. Hyto¨nen, H. Lohi, C. Mellersh,
J. Mickelson, A. Oberbauer, S. Schmutz, and C. Wade) for sharing whole-
genome sequencing data from control dogs; N. Russel for providing skull
photography; and C. Muller, K. McLellan, M. John, and K. Thomas for
providing animal photography. Additional thanks are given to G. Faulkner,
D. FitzPatrick, I. Jackson, M. McGrew, H. Sang, A. Balic, and R. Harrington
for their helpful suggestions. The mouse Smoc2 riboprobe was generously
provided by J. Rainger. J.J.S. is a University of Edinburgh Chancellor’s
fellow and received funding from the Wellcome Trust-University of Edin-
burgh Institutional Strategic Support Fund (ISSF2). The Roslin Institute re-
ceives strategic funding from the Biotechnology and Biosciences Research
Council: J.J.S. (BB/J004235/1 and BB/P013759/1) and M.D. (BB/J004316/1
and BB/P013732/1). J.J.S. and M.N. received funding from the Albert Heim
Foundation (grant 101 13.03.2012). T. Leeb received funding from the Albert
Heim Foundation (grant 105 09.10.2012). Funding for DECIPHER was pro-
vided by the Wellcome Trust.
Received: October 19, 2016
Revised: March 14, 2017
Accepted: April 27, 2017
Published: May 25, 2017
REFERENCES
1. Stockard, C.R. (1941). The Genetic and Endocrinic Basis for Differences in
Form and Behaviour (Philadelphia: The Wistar Institute of Anatomy and
Biology).
2. Wayne, R.R. (2001). Phylogeny and origin of the domestic dog. In The
Genetics of the Dog, A. Ruvinsky, and J. Sampson, eds. (CABI), pp. 1–14.
3. Harvey, R.G., and ter Haar, G. (2016). Brachycephalic obstructive airway
syndrome. In Ear, Nose and Throat Diseases of the Dog and Cat, R.G.
Harvey, and G. ter Haar, eds. (Devon: CRC Press), pp. 290–293.
4. Poncet, C.M., Dupre, G.P., Freiche, V.G., Estrada, M.M., Poubanne, Y.A.,
and Bouvy, B.M. (2005). Prevalence of gastrointestinal tract lesions in 73
brachycephalic dogs with upper respiratory syndrome. J. Small Anim.
Pract. 46, 273–279.
5. Sanchez, R.F., Innocent, G., Mould, J., and Billson, F.M. (2007). Canine
keratoconjunctivitis sicca: disease trends in a review of 229 cases.
J. Small Anim. Pract. 48, 211–217.
6. Collmann, H., So¨rensen, N., and Krauss, J. (2005). Hydrocephalus in cra-
niosynostosis: a review. Childs Nerv. Syst. 21, 902–912.
7. Wilkie, A.O.M., Byren, J.C., Hurst, J.A., Jayamohan, J., Johnson, D.,
Knight, S.J.L., Lester, T., Richards, P.G., Twigg, S.R.F., and Wall, S.A.
(2010). Prevalence and complications of single-gene and chromosomal
disorders in craniosynostosis. Pediatrics 126, e391–e400.
8. Schoenebeck, J.J., Hutchinson, S.A., Byers, A., Beale, H.C., Carrington,
B., Faden, D.L., Rimbault, M., Decker, B., Kidd, J.M., Sood, R., et al.1582 Current Biology 27, 1573–1584, June 5, 2017(2012). Variation of BMP3 contributes to dog breed skull diversity. PLoS
Genet. 8, e1002849.
9. Boyko, A.R., Quignon, P., Li, L., Schoenebeck, J.J., Degenhardt, J.D.,
Lohmueller, K.E., Zhao, K., Brisbin, A., Parker, H.G., vonHoldt, B.M.,
et al. (2010). A simple genetic architecture underlies morphological varia-
tion in dogs. PLoS Biol. 8, e1000451.
10. Quilez, J., Short, A.D., Martı´nez, V., Kennedy, L.J., Ollier, W., Sanchez, A.,
Altet, L., and Francino, O. (2011). A selective sweep of >8 Mb on chromo-
some 26 in the boxer genome. BMC Genomics 12, 339.
11. Bannasch, D., Young, A., Myers, J., Truve, K., Dickinson, P., Gregg, J.,
Davis, R., Bongcam-Rudloff, E., Webster, M.T., Lindblad-Toh, K., and
Pedersen, N. (2010). Localization of canine brachycephaly using an across
breed mapping approach. PLoS ONE 5, e9632.
12. Wayne, R.K. (1986). Cranial morphology of domestic and wild canids:
the influence of development on morphological change. Evolution 40,
243–261.
13. Drake, A.G., and Klingenberg, C.P. (2010). Large-scale diversification of
skull shape in domestic dogs: disparity and modularity. Am. Nat. 175,
289–301.
14. Pritchard, J.K., Stephens, M., and Donnelly, P. (2000). Inference of popu-
lation structure using multilocus genotype data. Genetics 155, 945–959.
15. Parker, H.G., Kim, L.V., Sutter, N.B., Carlson, S., Lorentzen, T.D., Malek,
T.B., Johnson, G.S., DeFrance, H.B., Ostrander, E.A., and Kruglyak, L.
(2004). Genetic structure of the purebred domestic dog. Science 304,
1160–1164.
16. Hayward, J.J., Castelhano, M.G., Oliveira, K.C., Corey, E., Balkman, C.,
Baxter, T.L., Casal, M.L., Center, S.A., Fang, M., Garrison, S.J., et al.
(2016). Complex disease and phenotype mapping in the domestic dog.
Nat. Commun. 7, 10460.
17. Parker, H.G., VonHoldt, B.M., Quignon, P., Margulies, E.H., Shao, S.,
Mosher, D.S., Spady, T.C., Elkahloun, A., Cargill, M., Jones, P.G., et al.
(2009). An expressed fgf4 retrogene is associated with breed-defining
chondrodysplasia in domestic dogs. Science 325, 995–998.
18. Choi, Y., Ishiguro, N., Shinagawa, M., Kim, C.J., Okamoto, Y., Minami, S.,
and Ogihara, K. (1999). Molecular structure of canine LINE-1 elements in
canine transmissible venereal tumor. Anim. Genet. 30, 51–53.
19. Miki, Y., Nishisho, I., Horii, A., Miyoshi, Y., Utsunomiya, J., Kinzler, K.W.,
Vogelstein, B., and Nakamura, Y. (1992). Disruption of the APC gene by
a retrotransposal insertion of L1 sequence in a colon cancer. Cancer
Res. 52, 643–645.
20. Gilbert, N., Lutz, S., Morrish, T.A., and Moran, J.V. (2005). Multiple fates of
L1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol.
25, 7780–7795.
21. Estecio, M.R.H., Gallegos, J., Dekmezian, M., Lu, Y., Liang, S., and Issa,
J.-P.J. (2012). SINE retrotransposons cause epigenetic reprogramming
of adjacent gene promoters. Mol. Cancer Res. 10, 1332–1342.
22. Han, J.S., Szak, S.T., and Boeke, J.D. (2004). Transcriptional disruption by
the L1 retrotransposon and implications for mammalian transcriptomes.
Nature 429, 268–274.
23. Speek, M. (2001). Antisense promoter of human L1 retrotransposon drives
transcription of adjacent cellular genes. Mol. Cell. Biol. 21, 1973–1985.
24. Mount, S.M. (1982). A catalogue of splice junction sequences. Nucleic
Acids Res. 10, 459–472.
25. Breathnach, R., Benoist, C., O’Hare, K., Gannon, F., and Chambon, P.
(1978). Ovalbumin gene: evidence for a leader sequence in mRNA and
DNA sequences at the exon-intron boundaries. Proc. Natl. Acad. Sci.
USA 75, 4853–4857.
26. Vannahme, C., Go¨sling, S., Paulsson, M., Maurer, P., and Hartmann, U.
(2003). Characterization of SMOC-2, a modular extracellular calcium-
binding protein. Biochem. J. 373, 805–814.
27. Rimbault, M., Beale, H.C., Schoenebeck, J.J., Hoopes, B.C., Allen, J.J.,
Kilroy-Glynn, P., Wayne, R.K., Sutter, N.B., and Ostrander, E.A. (2013).
Derived variants at six genes explain nearly half of size reduction in dog
breeds. Genome Res. 23, 1985–1995.
28. Melvin, V.S., Feng, W., Hernandez-Lagunas, L., Artinger, K.B., and
Williams, T. (2013). A morpholino-based screen to identify novel genes
involved in craniofacial morphogenesis. Dev. Dyn. 242, 817–831.
29. Bloch-Zupan, A., Jamet, X., Etard, C., Laugel, V., Muller, J., Geoffroy, V.,
Strauss, J.-P., Pelletier, V., Marion, V., Poch, O., et al. (2011).
Homozygosity mapping and candidate prioritization identify mutations,
missed by whole-exome sequencing, in SMOC2, causing major dental
developmental defects. Am. J. Hum. Genet. 89, 773–781.
30. Liu, P., Lu, J., Cardoso, W.V., and Vaziri, C. (2008). The SPARC-related
factor SMOC-2 promotes growth factor-induced cyclin D1 expression
and DNA synthesis via integrin-linked kinase. Mol. Biol. Cell 19, 248–261.
31. Yoshida, T., Vivatbutsiri, P., Morriss-Kay, G., Saga, Y., and Iseki, S. (2008).
Cell lineage in mammalian craniofacial mesenchyme. Mech. Dev. 125,
797–808.
32. Jiang, X., Iseki, S., Maxson, R.E., Sucov, H.M., and Morriss-Kay, G.M.
(2002). Tissue origins and interactions in the mammalian skull vault. Dev.
Biol. 241, 106–116.
33. Chai, Y., Jiang, X., Ito, Y., Bringas, P., Jr., Han, J., Rowitch, D.H., Soriano,
P., McMahon, A.P., and Sucov, H.M. (2000). Fate of the mammalian
cranial neural crest during tooth and mandibular morphogenesis.
Development 127, 1671–1679.
34. Cadieu, E., Neff, M.W., Quignon, P., Walsh, K., Chase, K., Parker, H.G.,
Vonholdt, B.M., Rhue, A., Boyko, A., Byers, A., et al. (2009). Coat variation
in the domestic dog is governed by variants in three genes. Science 326,
150–153.
35. Pazin, D.E., and Albrecht, K.H. (2009). Developmental expression of
Smoc1 and Smoc2 suggests potential roles in fetal gonad and reproduc-
tive tract differentiation. Dev. Dyn. 238, 2877–2890.
36. Uhlen, M., Fagerberg, L., Hallstro¨m, B.M., Lindskog, C., Oksvold, P.,
Mardinoglu, A., Sivertsson, A˚., Kampf, C., Sjo¨stedt, E., Asplund, A.,
et al. (2015). Proteomics. Tissue-based map of the human proteome.
Science 347, 1260419.
37. Song, C., Gu, X., Feng, C., Wang, Y., Gao, Y., Hu, X., and Li, N. (2011).
Evaluation of SNPs in the chicken HMGA2 gene as markers for body
weight gain. Anim. Genet. 42, 333–336.
38. Zhang, M., Pritchard, M.R., Middleton, F.A., Horton, J.A., and Damron,
T.A. (2008). Microarray analysis of perichondral and reserve growth plate
zones identifies differential gene expressions and signal pathways. Bone
43, 511–520.
39. Fusco, I., Babu, D., Mellone, S., Barizzone, N., Prodam, F., Fanelli, A.,
Muniswamy, R., Petri, A., Bellone, S., Bona, G., and Giordano, M.
(2016). Variations in the high-mobility group-A2 gene (HMGA2) are associ-
ated with idiopathic short stature. Pediatr. Res. 79, 258–261.
40. Tetens, J., Widmann, P., Ku¨hn, C., and Thaller, G. (2013). A genome-wide
association study indicates LCORL/NCAPG as a candidate locus for
withers height in German Warmblood horses. Anim. Genet. 44, 467–471.
41. Sahana, G., Ho¨glund, J.K., Guldbrandtsen, B., and Lund, M.S. (2015). Loci
associated with adult stature also affect calf birth survival in cattle. BMC
Genet. 16, 47.
42. Liu, R., Sun, Y., Zhao, G., Wang, F., Wu, D., Zheng, M., Chen, J., Zhang, L.,
Hu, Y., andWen, J. (2013). Genome-wide association study identifies Loci
and candidate genes for body composition and meat quality traits in
Beijing-You chickens. PLoS ONE 8, e61172.
43. Sasaki, T., Go¨hring, W., Mann, K., Maurer, P., Hohenester, E., Kn€auper, V.,
Murphy, G., and Timpl, R. (1997). Limited cleavage of extracellular matrix
protein BM-40 by matrix metalloproteinases increases its affinity for colla-
gens. J. Biol. Chem. 272, 9237–9243.
44. Go¨hring, W., Sasaki, T., Heldin, C.H., and Timpl, R. (1998). Mapping of the
binding of platelet-derived growth factor to distinct domains of the base-
ment membrane proteins BM-40 and perlecan and distinction from the
BM-40 collagen-binding epitope. Eur. J. Biochem. 255, 60–66.
45. Kupprion, C., Motamed, K., and Sage, E.H. (1998). SPARC (BM-40, osteo-
nectin) inhibits the mitogenic effect of vascular endothelial growth factor
on microvascular endothelial cells. J. Biol. Chem. 273, 29635–29640.46. Brekken, R.A., and Sage, E.H. (2000). SPARC, a matricellular protein: at
the crossroads of cell-matrix. Matrix Biol. 19, 569–580.
47. Feng, W., Leach, S.M., Tipney, H., Phang, T., Geraci, M., Spritz, R.A.,
Hunter, L.E., and Williams, T. (2009). Spatial and temporal analysis of
gene expression during growth and fusion of the mouse facial promi-
nences. PLoS ONE 4, e8066.
48. Termine, J.D., Kleinman, H.K., Whitson, S.W., Conn, K.M., McGarvey,
M.L., and Martin, G.R. (1981). Osteonectin, a bone-specific protein linking
mineral to collagen. Cell 26, 99–105.
49. Maier, S., Paulsson, M., and Hartmann, U. (2008). The widely expressed
extracellular matrix protein SMOC-2 promotes keratinocyte attachment
and migration. Exp. Cell Res. 314, 2477–2487.
50. Mommaerts, H., Esguerra, C.V., Hartmann, U., Luyten, F.P., and
Tylzanowski, P. (2014). Smoc2 modulates embryonic myelopoiesis during
zebrafish development. Dev. Dyn. 243, 1375–1390.
51. Firth, H.V., Richards, S.M., Bevan, A.P., Clayton, S., Corpas, M., Rajan, D.,
Van Vooren, S., Moreau, Y., Pettett, R.M., and Carter, N.P. (2009).
DECIPHER: database of chromosomal imbalance and phenotype in hu-
mans using Ensembl resources. Am. J. Hum. Genet. 84, 524–533.
52. Alfawaz, S., Fong, F., Plagnol, V., Wong, F.S.L., Fearne, J., and Kelsell,
D.P. (2013). Recessive oligodontia linked to a homozygous loss-of-func-
tion mutation in the SMOC2 gene. Arch. Oral Biol. 58, 462–466.
53. Sulem, P., Helgason, H., Oddson, A., Stefansson, H., Gudjonsson, S.A.,
Zink, F., Hjartarson, E., Sigurdsson, G.T., Jonasdottir, A., Jonasdottir,
A., et al. (2015). Identification of a large set of rare complete human knock-
outs. Nat. Genet. 47, 448–452.
54. Maccoux, L.J., Clements, D.N., Salway, F., and Day, P.J.R. (2007).
Identification of new reference genes for the normalisation of canine
osteoarthritic joint tissue transcripts from microarray data. BMC Mol.
Biol. 8, 62.
55. Li, H., and Durbin, R. (2010). Fast and accurate long-read alignment with
Burrows-Wheeler transform. Bioinformatics 26, 589–595.
56. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K.,
Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., and
DePristo, M.A. (2010). The Genome Analysis Toolkit: a MapReduce frame-
work for analyzing next-generation DNA sequencing data. Genome Res.
20, 1297–1303.
57. Ye, K., Schulz, M.H., Long, Q., Apweiler, R., and Ning, Z. (2009). Pindel: a
pattern growth approach to detect break points of large deletions andme-
dium sized insertions from paired-end short reads. Bioinformatics 25,
2865–2871.
58. Cingolani, P., Patel, V.M., Coon, M., Nguyen, T., Land, S.J., Ruden,
D.M., and Lu, X. (2012). Using Drosophila melanogaster as a model for
genotoxic chemical mutational studies with a new program, SnpSift.
Front. Genet. 3, 35.
59. Ward, L.D., and Kellis, M. (2012). HaploReg: a resource for exploring chro-
matin states, conservation, and regulatory motif alterations within sets of
genetically linked variants. Nucleic Acids Res. 40, D930–D934.
60. Kircher, M., Witten, D.M., Jain, P., O’Roak, B.J., Cooper, G.M., and
Shendure, J. (2014). A general framework for estimating the relative path-
ogenicity of human genetic variants. Nat. Genet. 46, 310–315.
61. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A.R.,
Bender, D., Maller, J., Sklar, P., de Bakker, P.I.W., Daly, M.J., and
Sham, P.C. (2007). PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575.
62. Chang, C.C., Chow, C.C., Tellier, L.C., Vattikuti, S., Purcell, S.M., and Lee,
J.J. (2015). Second-generation PLINK: rising to the challenge of larger and
richer datasets. Gigascience 4, 7.
63. Falush, D., Stephens, M., and Pritchard, J.K. (2007). Inference of popula-
tion structure using multilocus genotype data: dominant markers and null
alleles. Mol. Ecol. Notes 7, 574–578.
64. Zhou, X., and Stephens, M. (2012). Genome-wide efficient mixed-model
analysis for association studies. Nat. Genet. 44, 821–824.Current Biology 27, 1573–1584, June 5, 2017 1583
65. Delaneau, O., Zagury, J.-F., andMarchini, J. (2013). Improvedwhole-chro-
mosome phasing for disease and population genetic studies. Nat.
Methods 10, 5–6.
66. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S.,
Batut, P., Chaisson, M., and Gingeras, T.R. (2013). STAR: ultrafast univer-
sal RNA-seq aligner. Bioinformatics 29, 15–21.
67. Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of
fold change and dispersion for RNA-seq data with DESeq2. Genome
Biol. 15, 550.
68. Liao, Y., Smyth, G.K., and Shi, W. (2013). The Subread aligner: fast,
accurate and scalable read mapping by seed-and-vote. Nucleic Acids
Res. 41, e108.
69. Robinson, J.T., Thorvaldsdo´ttir, H., Winckler, W., Guttman, M., Lander,
E.S., Getz, G., and Mesirov, J.P. (2011). Integrative genomics viewer.
Nat. Biotechnol. 29, 24–26.
70. Schneider, C.A., Rasband, W.S., and Eliceiri, K.W. (2012). NIH Image to
ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675.
71. Klingenberg, C.P. (2011). MorphoJ: an integrated software package for
geometric morphometrics. Mol. Ecol. Resour. 11, 353–357.
72. Pfaffl, M.W. (2001). A newmathematical model for relative quantification in
real-time RT-PCR. Nucleic Acids Res. 29, e45.1584 Current Biology 27, 1573–1584, June 5, 201773. Nieto, M.A., Patel, K., andWilkinson, D.G. (1996). In situ hybridization anal-
ysis of chick embryos in whole mount and tissue sections. Methods Cell
Biol. 51, 219–235.
74. Klingenberg, C.P., Barluenga, M., and Meyer, A. (2002). Shape analysis of
symmetric structures: quantifying variation among individuals and asym-
metry. Evolution 56, 1909–1920.
75. DePristo, M.A., Banks, E., Poplin, R., Garimella, K.V., Maguire, J.R., Hartl,
C., Philippakis, A.A., del Angel, G., Rivas, M.A., Hanna, M., et al. (2011).
A framework for variation discovery and genotyping using next-generation
DNA sequencing data. Nat. Genet. 43, 491–498.
76. Van der Auwera, G.A., Carneiro, M.O., Hartl, C., Poplin, R., del Angel, G.,
Levy-Moonshine, A., Jordan, T., Shakir, K., Roazen, D., Thibault, J., et al.
(2013). From FastQ data to high confidence variant calls: the Genome
Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformatics 43,
11.10.1–11.10.33.
77. Freedman, A.H., Gronau, I., Schweizer, R.M., Ortega-Del Vecchyo, D.,
Han, E., Silva, P.M., Galaverni, M., Fan, Z., Marx, P., Lorente-Galdos,
B., et al. (2014). Genome sequencing highlights the dynamic early history
of dogs. PLoS Genet. 10, e1004016.
78. Bai, B., Zhao, W.-M., Tang, B.-X., Wang, Y.-Q., Wang, L., Zhang, Z., Yang,
H.-C., Liu, Y.-H., Zhu, J.-W., Irwin, D.M., et al. (2015). DoGSD: the dog and
wolf genome SNP database. Nucleic Acids Res. 43, D777–D783.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Biological Samples
Canis familiaris Various veterinary
referral hospitals
N/A
Chemicals, Peptides, and Recombinant Proteins
Trizol Life Technologies 15596026
RNAlater Life Technologies AM7020M
Critical Commercial Assays
CanineHD Whole-Genome Genotyping SNP BeadChip Illumina WG-440-1001
Truseq DNA nano kit Illumina FC-121-4001
TruSeq Stranded mRNA Library Prep Kit High
Throughput
Illumina RS-122-2103
Illumina TruSeq Nano DNA library prep HT SeqLab 20000903
Deposited Data
RNA and DNA sequencing data This paper ENA: PRJEB17926, http://www.ebi.ac.uk/ena
Dog reference genome (CanFam3.1, ENSEMBL
release-85)
ENSEMBL http://www.ensembl.org/index.html
Dog genotypes This paper http://dx.doi.org/10.5061/dryad.cq612
Dog genetic variants Dog Biomedical Variant
Database Consortium
(tosso.leeb@vetsuisse.
unibe.ch)
N/A
Experimental Models: Organisms/Strains
Mouse: Smoc2tm1.1(KOMP)Vlcg The Jackson Laboratory https://www.jax.org
Mouse embryos Roslin Institute Biological
Research Facility
N/A
Chicken embryos NARF http://www.narf.ac.uk
Oligonucleotides
gDNA targeted primer: SMOC2 Forward: GGCAGGGG
ATGGGGAAGGCT
This paper N/A
gDNA targeted primer: SMOC2 Reverse (ancestral):
ACTGTGTGCTTTGCCCAAACTCA
This paper N/A
gDNA targeted primer: SMOC2 Reverse (derived):
TGCCCATAAAGTTCAGGGTCCACT
This paper N/A
gDNA targeted primer: IGF1 Forward: CACTGATCCAG
AAGAATCCAACT
[27] N/A
gDNA targeted primer: IGF1 Reverse: CAAAGAACCA
TGTAAGCCTATTTGT
[27] N/A
gDNA targeted primer: STC2 Forward: ATACAATCC
ACCTAGTGTCCCCAACCAT
[27] N/A
gDNA targeted primer: STC2 Reverse: GGCCACAGC
CCCTTTAAT
[27] N/A
gDNA targeted primer: SMAD2 Forward: GCTTCAAG
TCAGTGTGCTCC
This paper N/A
gDNA targeted primer: SMAD2 Reverse: CGTATTTGT
TGCTGCTGGGT
This paper N/A
gDNA targeted primer: SMAD2 Reverse: AGAGCCCTG
ACATCATGACC
This paper N/A
(Continued on next page)
Current Biology 27, 1573–1584.e1–e6, June 5, 2017 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
gDNA targeted primer: FGF4 retrogene Forward: CACA
CAGATGGACCATGAAA
This paper N/A
gDNA targeted primer: FGF4 retrogene Reverse
(ancestral): TTTTAGATTCCGCACATGAG
This paper N/A
gDNA targeted primer: FGF4 retrogene Reverse
(derived): CTCTTTGAACTTGCACTCCTC
This paper N/A
gDNA targeted primer: BMP3 Forward: GATACAGG
AGATTGTGCCAAATGGGTAA
[8] N/A
gDNA targeted primer: BMP3 Reverse: CTCCTGGTGG
AAATCGTCAGTCTATCTG
[8] N/A
gDNA targeted primer: CFA30 QTL Forward: AGGGA
TAGTCCAGCTCCAAGGCTGGTAT
This paper N/A
gDNA targeted primer: CFA30 QTL Reverse: CTCTTTC
AGGCTTCCCCAGTTGTACCTA
This paper N/A
gDNA targeted primer: IGF1R Forward: AGATGACCAA
CCTCAAGGATATT
[27] N/A
gDNA targeted primer: IGF1R Reverse: AGTCCTGC
CATCCCACAAAG
[27] N/A
gDNA targeted primer: GHR(1) & GHR(2) Forward:
GCTCTCCGTTAAATCAAGCTG
[27] N/A
gDNA targeted primer: GHR(1) & GHR(2) Reverse:
AAGGAGAGAGGTGTTGTTGGT
[27] N/A
cDNA targeted primer: SMOC2 Exon 2/3 Forward:
TGCTTATCGAGGAAATTGCAG
This paper N/A
cDNA targeted primer: SMOC2 Exon 2/3 Reverse:
TGGGATGAACACCTGCTGTA
This paper N/A
cDNA targeted primer: SMOC2 Exon 10/11 Forward:
CGCGCTCTCTACCGACAT
This paper N/A
cDNA targeted primer: SMOC2 Exon 10/11 Reverse:
GGGGTCGGGTTCTGAGAG
This paper N/A
cDNA targeted primer: MRPS7 Forward: AGTGCAG
GGAGAAGAAGCAC
[54] N/A
cDNA targeted primer: MRPS7 Reverse: CAGCAGCTC
GTGTGACAACT
[54] N/A
Software and Algorithms
Read alignment: bwa v0.7.8 [55] https://sourceforge.net/projects/bio-bwa/files/
Variant caller: GATK v3.7 [56] http://gatkforums.broadinstitute.org/gatk
WGS utility: Picard http://broadinstitute.
github.io/picard
https://github.com/broadinstitute/picard/releases
Structural variant caller: Pindel v0.2.3 [57] http://gmt.genome.wustl.edu/packages/pindel/
Annotation: SNPsift v4.0 [58] http://snpeff.sourceforge.net/SnpSift.html
Effect prediction: HaploReg v4.1 [59] N/A
Effect prediction: CADD v3.1 [60] N/A
Utility: PLINK v1.07 [61] http://zzz.bwh.harvard.edu/plink/
Utility: PLINK v1.90 beta [62] https://www.cog-genomics.org/plink2
Admixture assessments: STRUCTURE v2.3 [63] http://web.stanford.edu/group/pritchardlab/
structure_software/release_versions/v2.3.4/html/
structure.html
Linear mixed model: GEMMA v0.94.1 [64] http://www.xzlab.org/software.html
Phasing: SHAPEIT v2.r837 [65] https://mathgen.stats.ox.ac.uk/genetics_software/
shapeit/shapeit.html
(Continued on next page)
e2 Current Biology 27, 1573–1584.e1–e6, June 5, 2017
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Graphics and data analysis: R v3.3.0 The Comprehensive
R Archive Network
(CRAN)
https://cran.r-project.org
RNaseq alignment: STAR v2.5.1b [66] https://github.com/alexdobin/STAR
RNaseq analysis: DESeq2 v1.12.14 [67] https://bioconductor.org
RNaseq analysis: RSubread v1.22.3 [68] https://bioconductor.org
Data visualization: Integrative Genomics Viewer
v2.3.59
[69] http://software.broadinstitute.org/software/igv/
DICOM reconstruction and landmarking:
CheckPoint v2016.11.21.0711 WIN x64
Stratovan https://www.stratovan.com
ImageJ v1.50 g [70] https://imagej.nih.gov/ij/
Geometric morphometrics: MorphoJ v1.06c [71] http://www.flywings.org.uk/morphoj_page.htm
Other
KOD Xtreme HotStart Polymerase Merck 71975-3
Saliva sample collection kit Peformagene PG-100
Lysing matrix D 2mL tube MPBio 116913050
RNeasy Minikit QIAGEN C-74104
SuperScript III First- Strand Synthesis SuperMix Life Technologies 11752050CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jeffrey
Schoenebeck (jeff.schoenebeck@roslin.ed.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Study Participants. In total, 374 canine patients (212 male, 162 female) were recruited from four veterinary practices across the
United Kingdom and Switzerland: The Hospital for Small Animals, The University of Edinburgh, UK; Davies Veterinary Specialists,
Hertfordshire, UK; Small Animal Medicine and Surgery Group, The Royal Veterinary College, Hertfordshire, UK; The Division of
Clinical Radiology, The Vetsuisse Faculty University of Bern, Switzerland. Canine participants were admitted to referral practices
for diagnostic imaging. Owners provided breed identity (when known) and consent for their dogs’ participation in our study. Spiral
or sequential computed tomography (CT) scans were acquired at one or two millimeter slice thickness. All scans were reviewed
by a radiologist to ensure that pathologies or injuries did not compromise exterior skull integrity. All 374 individuals are represented
in the viscerocranium and neurocranium dataset. Due to mandibular pathologies, a subset of 355 individuals were represented in the
mandibular dataset. Participants were aged twenty-four months or above at the time of diagnostic imaging and represent eighty-four
Kennel Club (UK) recognized breeds and eighty-three mixed-breed individuals (Table S1). Use of referral patient diagnostic imaging
and biomaterial was reviewed and approved by the R(D)SVS’s Veterinary Ethics Review Committee.
Mouse (C57BL/6) and chick (Isa Brown) embryos used for histology were surplus biomaterial harvested prior to this study. Mouse
and chick work was conducted in accordance to animal use guidelines of the Roslin Institute under UK Home Office license and with
ethical review.
METHOD DETAILS
DNA Extraction and Microarray Genotyping
Genomic DNA (gDNA) was extracted from residual diagnostic whole blood stored in EDTA at 4C,20C or at80C; discarded soft
tissue following surgery stored at 20C; or oral saliva swabs (Performagene, DNA Genotek). DNA was extracted from whole blood
using an adaption of Boodram salt-based protocol (http://www.protocol-online.org/prot/Protocols/Extraction-of-genomic-DNA-
from-whole-blood-3171.html). For the gDNA extraction from soft tissue 750 mL extraction buffer (10 mM Tris pH 8.0, 10 mM
EDTA pH 8.0, 1% SDS, 100 mMNaCl), 80 mL 0.5 M Dithiothreitol and 15 mL Protein K solution (20mg/mL, Ambion, Life Technologies)
were added to approximately 4 mm3 of tissue. Following overnight digestion, 270 mL saturated NaCl solution was added and centri-
fuged. One mL absolute ethanol was added to 500 mL supernatant to precipitate the gDNA. gDNA was spun and following centrifu-
gation, washed with 70% ethanol. All gDNA samples were resuspended and stored in TE buffer 4C. Oral mucosa swabs were
processed in accordance with the Performagene protocol (http://www.dnagenotek.com/US/pdf/PD-PR-083.pdf). GenotypesCurrent Biology 27, 1573–1584.e1–e6, June 5, 2017 e3
were produced using the 170,000 SNP Illumina CanineHD Whole-Genome Genotyping BeadChip by Edinburgh Genomics, UK.
Genotype calls were mapped to CanFam3.1 coordinates (Broad, September 2011).
RNA Extraction and qPCR
Testeswereselected formessengerRNA (mRNA)extractiondue to theunattainability of appropriateembryonic-stage tissueor healthy
adult tissues in the dog. SMOC2was assumed to be expressed in the testis based on evidence in other species [35, 36] (http://www.
proteinatlas.org/). gDNA and mRNA were extracted from testes snap frozen and stored at 80C in RNAlater. gDNA was extracted
from tissue following the ThermoFisher Scientific protocol (http://www.thermofisher.com/uk/en/home/references/protocols/
nucleic-acid-purification-and-analysis/rna-protocol/genomic-dna-preparation-from-rnalater-preserved-tissues.html). gDNA sam-
plesweregenotyped for theSMOC2LINE-1 insertion toallow targetedextractionofRNA from testes. Fromour screening,we identified
nine subjects: 3 ancestral (1 Italian greyhound, 1whippet, 1Yorkshire terrier), 3 heterozygous (1Papillon, 2Cavalier KingCharles span-
iels), and 3 homozygous derived (1 bulldog, 1 French bulldog, 1 pug). For RNA extractions, 1mL chilled Trizol was added to 100mg of
testes in amatrix D lysis tube and homogenized using a FastPrep for two 20 s intervals at 4m/s. Sampleswere incubated at room tem-
perature for 5min following homogenization. Next, 200 mL 1-bromo-3-chloropropane (BCP)was added to each sample, shaken vigor-
ously for 15 s and incubated at room temperature for 3 min. Samples were centrifuged for at 12,000G for 15min at 4C and the upper
aqueous phase was subsequently transferred to a fresh tube. RNA was cleaned using the QIAGEN RNeasy Minikit following
and including optional steps provided in the RNeasy Mini Kit Part 1 protocol. A DNase step was not used.
Complementary DNA (cDNA) was produced from 1 mg total RNA using the SuperScript III First-Strand Synthesis SuperMix
(Invitrogen) following the product protocol with oligo(dT) primers. Primers for target genes were designed to be intron-spanning using
the online Roche design center. Primers for reference housekeeping genes were acquired from previously published work [54]. Rela-
tive expression profiles for SMOC2 were determined using the Roche Life Sciences probe-based real-time qPCR assay with a
LightCycler 480 system (Roche). All RNA profiles were analyzed in triplicate for both technical and biological replicates. Expression
of target genes were normalized with mitochondrial ribosomal protein S7 (MRPS7). Relative quantification levels were corrected for
primer efficiency [72].
Sequencing Library Preparations
The integrity of genomics DNA and total RNA samples were verified by Agilent Tapestation. All RNA samples scored RIN values
greater than 8.0. DNA and RNA Library preparation and sequencing services were provided by Edinburgh Genomics (UK). Briefly,
DNA libraries were prepared using either SeqLab TruSeq Nano DNA library prep HT or Illumina Truseq DNA nano DNA library
kits. Paired-end libraries sequences on the Illumina HiSeq 2500 had an average insert size of 550 bp and read length of 125 bp.
Paired-end DNA libraries sequenced on the HiSeq X platform had an average insert size of 450 bp and 150 bp read length.
For RNA, TruSeq stranded libraries were prepared from nine preparations of total RNA according to manufacturer’s protocol. Bar-
coded libraries were sequenced on three lanes of an Illumina HiSeq 4000, producing 150 bp paired-end reads (96 million + 96 million
reads per library).
Histology
Whole-mount Smoc2 in situ hybridization was performed per Nieto et al. (1996) [73].
QUANTIFICATION AND STATISTICS
Morphometrics
3D reconstructions of anonymised canine skull CT scans were generated in Stratovan Checkpoint software (v2014.11.28.0324) and
anatomical substructures (cranium and mandible) of resulting isosurfaces were manually landmarked by a single analyst (Figure S1).
Breed designations were hidden from the analyst and CTs were analyzed in a random order. Fifty-six cranial and thirty mandibular
landmarks were selected to capture morphological variation. Raw 3D coordinates of cranial and mandibular subsets were reformat-
ted using custom R (v3.2.5) scripts and analyzed using MorphoJ (v1.06c) [71]. The cranial landmark subset was further divided into
neurocranium (n = 18) and viscerocranium (n = 25) landmarks (Figure S1). A generalized Procrustes fit was used to scale, transpose,
and rotate landmarks [74]. A by-product of the Procrustes fit is the centroid size (the amount of scaling used in the fit). The neuro-
cranium centroid size was used as a proxy of body size (see below). In order to remove allometric effects, a regression consisting
of 10,000 permutations using the neurocranium’s centroid size (independent variable) was run on the viscerocranium and mandible
symmetric coordinates. A covariance matrix was calculated from the regression residuals. Decomposition of the distance matrix by
principal component analysis (PCA) produced components; each principal component (PC) explains successively smaller tranches
of morphological variation. Viscerocranium PC1 (without allometry), mandible PC1 (without allometry) and neurocranium centroid
size were subsequently used as phenotypic outcomes for GWAS.
Lateral and dorsoventral radiographs of four C57BL/6JN background controls and eight Smoc2/ mice (Smoc2tm1.1(KOMP)Vlcg
allele produced by The Jackson Laboratory, USA) aged thirteen weeks were landmarked in ImageJ (v1.50 g) [70] using the
PointPicker plugin (male = 5, female = 7). The raw 2D coordinates for nine lateral and fifteen dorsoventral landmarks were
exported from ImageJ and analyzed in MorphoJ. Lateral and dorsoventral landmarks were analyzed as using the same approach.
A generalized Procrustes fit was used to create a best fit for landmarks. A covariance matrix was calculated using the Procrustese4 Current Biology 27, 1573–1584.e1–e6, June 5, 2017
distance matrix of the whole head prior to PCA. A two-tailed Student’s t test assessed PC1 distribution for sex and Smoc2 back-
ground. Principal component plots were generated using a custom R script. Additional phenotypic detail regarding these mice
are available form the International Mouse Phenotyping Consortium (http://www.mousephenotype.org).
Genotype Analyses
PLINK (v1.07) [61] was used to remove SNPs with a minor-allele frequency < 0.05 and individuals with > 0.1 missing markers.
Genotypes were prephased using SHAPEIT (v2.r837) [65] using default parameters that includes 500 states. Imputations were
done with Minimac2 (2014.9.15) using 40 rounds and 1,000 states. Post-processing by fcGene (v1.0.7) removed genotypes with
R2 < 0.3 and minor allele frequency < 0.05. In total, 139,260 SNPs remained for analysis.
Population structure was assessed using STRUCTURE (v2.3) [63]. GEMMA (v0.94.1) [64], which incorporates a kinship matrix in its
implementation of univariate linear mixed models, was used to perform genome-wide association tests. Sex and up to ten principal
components (generated from SNP genotype data in PLINK v1.9 [62]) were used as covariates – ten covariates for neurocranium and
five for viscerocranium andmandible. The number of PCs included was determined by evaluation of Q-Qplots. p values generated in
the association tests were used for Q-Qplots; using the aforementioned parameters returned l values (genomic inflation factors)
within the range 0.954 – 1.000 (Figure 2 and Figure S4). Index SNPs as well as markers in linkage disequilibrium (r2 > 0.2) to them
were pruned from the dataset using PLINK and GEMMA association analyses were re-run. Observed p values plotted concordantly
with expected values, indicating minimal population-based inflation. A Bonferroni correction was used to determine a significance
threshold for association tests (-log10[0.05/139,260] = 6.44). Manhattan plots and Q-Qplots were generated using custom
scripts in R.
Fine Mapping
Haplotype association testing was done using ten SNP sliding windows across 1 megabase (Mb) flanking regions of significant
SNPs in canine chromosome (CFA) 1. SHAPEIT was used to phase genotypes. Haplotypes for the region of interest were ordered
by individual viscerocranium PC1 score and colored by genotypes that matched the consensus sequence. The borders of the critical
interval were defined by a minimum of three meiotic recombination events across the brachycephalic individuals with a viscerocra-
nium PC1 < 0.2.
Variant Filtering
Eight brachycephalic dogs were resequenced on an Illumina HiSeq 2000 (Edinburgh Genomics, UK) to approximately 14-33X depth.
Another thirty dogswere resequenced using the Illumina HiSeq X platform to > 40X depth. Resulting paired-end readswere aligned to
the reference genome (CanFam3.1, Broad September 2011) using bwa (v0.7.8) [55]. SNPs and small INDEL variants within the critical
interval (CFA1:55850299-56037676) were called using GATK (v3.7) [56, 75, 76]. We compared our variant calls to those of three-hun-
dred and four dogs and wild canids made available to the DBVCD consortium members and an additional five canids (1 Basenji,
4 wolves) from the DoGSD database [77, 78]. Variants were hard filtered using SnpSift (v4.0) [58]. Because their deep coverage
and large insert sizes (> 450bp), we used our thirty-eight re-sequenced dogs to call structural variants; variants were called using
Pindel (v0.2.3) [57]. Filtering criteria for both SNPs/INDELS and large structural variants were determined by the presence of the
twelve SNP haplotype across selected brachycephalic and dolichocephalic individuals whose skull phenotypes were confirmed
(Table S4). Our filtering criteria were based on five logical assumptions. First, genomes from brachycephalic dogs with the twelve
SNP haplotype were assumed to carry, or to be fixed for, the causal variant(s) within the CFA1 critical interval. Second, haplotype
sharing at the CFA1 locus suggests identity-by-descent; therefore brachycephalic dogs with the twelve SNP haplotype inherited
the same causal variant(s) from a common ancestor. Third, as the dog assembly is based on the genome of a boxer (a brachycephalic
dog that was fixed for the twelve SNP haplotype), the causal variant(s) could be present in the reference assembly as reference
allele(s). Fourth, we expected that the causal variant(s) are derived and therefore absent from wild canid populations such as
dogs’ ancestor, the gray wolf. Lastly, dolichocephalic dogs without the associated twelve SNP haplotype cannot carry the causal
variant(s).
qRT-PCR
All RNA profiles were analyzed in triplicate for both technical and biological replicates. Expression of target genes were normalized
with mitochondrial ribosomal protein S7 (MRPS7). Relative quantification levels were corrected for primer efficiency [72].
RNA-Seq
FASTQ files were aligned using STAR to the dog reference genome (CanFam3.1, ENSEMBL release-85). Annotated junctions were
downloaded from ENSEMBL (ftp.ensembl.org/pub/release-85/gtf/canis_familiaris/Canis_familiaris.CanFam3.1.85.gtf.gz). Align-
ment was performed in two passes as instructed by the user manual. Using Picard tools (http://broadinstitute.github.io/picard),
read groups were added, bam files weremerged by sample, and reads weremarked for duplicates. Using featureCounts, an analysis
tool of the RSubread package (RSubread v1.22.3 installed on R v3.3.0), we quantifiedmapped reads to genes. Differential expression
analysis was conducted at the gene level using the R package DESeq2 (v1.12.4) by comparing homozygous SMOC2 LINE-1 carriersCurrent Biology 27, 1573–1584.e1–e6, June 5, 2017 e5
compared to non-carriers (three each). Detection of allelic imbalance was made possible by two of the three heterozygous dogs
described above (1 Cavalier King Charles spaniel, 1 Papillon), as these dogs were also heterozygous for the C/T SNP in exon 8
(chr1:55939143) of SMOC2.
Generation Scotland: Scottish Family Health Study
We used whole exome sequences from the Generation Scotland: Scottish Family Health Study (GS:SFHS). Study participants had
been originally recruited for population-based studies of complex traits. Details regarding the design and sequencing of human par-
ticipants is described elsewhere. We extracted all sequence variants in SMOC2 which passed GATK recalibration [56]. Putative
regulatory elements and functional roles of the extracted variants were assessed by the ENCODE-based prediction tool HaploReg
(v4.1) [59]. To assess the predicted consequences of the variants, we examined their C-scores, which indicate the ‘deleteriousness’
of a given mutation using combined annotation dependent depletion (CADD, v3.1) [60].
DATA AND SOFTWARE AVAILABILITY
DNA-seq and RNA-seq data are publicly available at the European Nucleotide Archive under primary accession number ENA:
PRJEB17926. Genotypes are available at Dryad Digital Repository (http://datadryad.org). The Dryad Digital Repository DOI for
the genotype data reported in this paper is Dryad: 10.5061/dryad.cq612.
ADDITIONAL RESOURCES
DECIPHER
This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the
data is available from https://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. The DECIPHER database was
searched for variants in human SMOC2 with reported craniofacial phenotypes.e6 Current Biology 27, 1573–1584.e1–e6, June 5, 2017
